NeuroSense Therapeutics Ltd. Earnings Per Share (Basic)
NeuroSense Therapeutics Ltd. (NRSN) reported Earnings Per Share (Basic) of -$0.44 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-03-31
| Period end | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 12 month |
|---|---|---|
| 2025-12-31 | -$0.44 20-F · filed 2026-03-31 | |
| 2025-06-30 | -$0.19 6-K · filed 2025-08-01 | |
| 2024-12-31 | -$0.54 20-F · filed 2026-03-31 | |
| 2024-06-30 | -$0.37 6-K · filed 2025-08-01 | |
| 2023-12-31 | -$0.74 20-F · filed 2026-03-31 | |
| 2023-06-30 | -$0.55 6-K · filed 2024-09-30 | |
| 2022-12-31 | -$0.91 20-F · filed 2025-04-07 | |
| 2021-12-31 | -$0.52 6-K · filed 2024-06-17 |